Scarica l'app Stockscreener
2.41
2.81%
-0.08
Dopo l'orario di chiusura:
2.41
Precedente Chiudi:
$2.49
Aprire:
$2.46
Volume 24 ore:
64,180
Relative Volume:
0.47
Capitalizzazione di mercato:
$268.76M
Reddito:
-
Utile/perdita netta:
$-11.05M
Rapporto P/E:
-9.255
EPS:
-0.2604
Flusso di cassa netto:
$2.18M
1 W Prestazione:
+1.68%
1M Prestazione:
+2.54%
6M Prestazione:
-28.19%
1 anno Prestazione:
-25.54%
Intervallo 1D:
$2.32
$2.46
Intervallo di 1 settimana:
$2.25
$2.51
Portata 52W:
$1.98
$4.7399
Waldencast Plc Stock (WALD) Company Profile
Nome
Waldencast Plc
Settore
Industria
Telefono
(917) 546-6828
Indirizzo
10 BANK STREET, SUITE 560, WHITE PLAINS
Confronta WALD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WALD
Waldencast Plc
|
2.41 | 298.92M | 0 | -11.05M | 2.18M | -0.2604 |
|
PG
Procter Gamble Co
|
158.81 | 371.19B | 83.93B | 15.50B | 15.03B | 6.30 |
|
UL
Unilever Plc Adr
|
61.04 | 147.94B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
88.49 | 71.88B | 19.95B | 2.90B | 3.47B | 3.54 |
|
KVUE
Kenvue Inc
|
22.52 | 43.52B | 15.30B | 1.06B | 1.45B | 0.55 |
|
KMB
Kimberly Clark Corp
|
127.75 | 42.77B | 19.75B | 2.47B | 2.39B | 7.34 |
Waldencast Plc Stock (WALD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-22 | Iniziato | Alliance Global Partners | Buy |
| 2024-12-16 | Iniziato | TD Cowen | Hold |
| 2024-10-25 | Iniziato | Canaccord Genuity | Buy |
| 2024-05-01 | Reiterato | Telsey Advisory Group | Outperform |
| 2023-07-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
Waldencast Plc Borsa (WALD) Ultime notizie
Gore Range Capital Announces Sale of Novaestiq Corp. to Waldencast - Greenville Online
What analysts say about Waldencast plc Equity Warrant stockConsistently outstanding ROI - Autocar Professional
Croma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast - Infosalus
What analysts say about Waldencast plc stockFree Stock Market Forecast Reports - Autocar Professional
Is Waldencast plc a good long term investmentAccelerated earnings growth - Autocar Professional
Waldencast plc Stock Analysis and ForecastAccelerated wealth building - Autocar Professional
Waldencast to Acquire Novaestiq, US Rights to Saypha Line of Injectable Hyaluronic Acid Gels - MarketScreener
Waldencast Acquires Novaestiq and U.S. Rights to Saypha® - TipRanks
Waldencast acquires Novaestiq to expand Obagi Medical into injectables By Investing.com - Investing.com South Africa
Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand - The Manila Times
Waldencast Acquires Novaestiq Corp, Expanding Obagi Medical's Injectable Product Portfolio and Market Reach - Nasdaq
Evolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in France - Yahoo.co
Waldencast acquires Novaestiq Corp. and U.S. rights to leading injectable hyaluronic acid gel line, Saypha, under the Obagi Medical brand - MarketScreener
Waldencast Doubles Market Reach to $4.2B Through Major Aesthetics Acquisition and Injectable Product Rights - Stock Titan
Waldencast plc Equity Warrant Stock Analysis and ForecastRapid portfolio appreciation - jammulinksnews.com
Is Waldencast plc Equity Warrant a good long term investmentBreakthrough stock performance - jammulinksnews.com
What drives Waldencast plc Equity Warrant stock priceDouble-digit growth - printweek.in
What drives Waldencast plc stock priceExceptional growth trajectory - jammulinksnews.com
How Waldencast plc stock reacts to Fed policy changesWeekly Double Return List - Newser
Will Waldencast plc Equity Warrant stock split in the near future200 Percent Profit Outlook - beatles.ru
Waldencast Plc Azioni (WALD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.33%
1.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):